SciCombinator

Discover the most talked about and latest scientific content & concepts.

G Dranitsaris, B Yu, J King, S Kaura and A Zhang
Abstract
Paclitaxel and docetaxel are commonly used for metastatic breast cancer in the People’s Republic of China. To improve the safety and efficacy of paclitaxel, an albumin-bound formulation (nab) is now available in the People’s Republic of China (Abraxane(®)). To provide health economic data for the key stakeholders, a cost-utility analysis comparing nab-paclitaxel to docetaxel, both as alternatives to paclitaxel, was conducted.
Tweets*
3
Facebook likes*
0
Reddit*
0
News coverage*
0
Blogs*
0
SC clicks
0
Concepts
Health economics, People's Republic of China, Metastasis, Cancer, Republic of China, North Korea, Chemotherapy, Breast cancer
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com